AbbVie to Buy ImmunoGen for More Than $10 Billion 0 30.11.2023 15:51 The Wall Street Journal AbbVie has agreed to buy ImmunoGen for about $10.1 billion in a deal that speeds the biopharmaceutical company’s entry into the commercial market for ovarian cancer. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
